A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

NCT07441252 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity and Elevated Liver Fat

Interventions

DRUG: Maridebart cafraglutide
DRUG: Placebo

Sponsor

Amgen